Survodutide Research Peptide: A Balanced Dual GLP‑1/Glucagon Receptor Agonist for Advanced Metabolic Studies
If your research investigates the complex interplay between appetite suppression, energy expenditure, and metabolic regulation, Survodutide research peptide (also known as BI 456906) offers a precisely defined and mechanistically advanced synthetic tool. Survodutide is a synthetic 29‑amino‑acid peptide engineered as a balanced dual agonist of the glucagon receptor (GCGR) and the glucagon‑like peptide‑1 receptor (GLP‑1R).
Unlike single‑receptor agonists or unbalanced dual agonists, Survodutide’s balanced activation of both pathways provides a comprehensive approach to metabolic research: GLP‑1R agonism suppresses appetite and enhances glucose‑dependent insulin secretion, while GCGR activation promotes energy expenditure, fatty acid oxidation, and thermogenesis. This makes Survodutide research peptide an invaluable tool for laboratories investigating obesity, metabolic dysfunction‑associated steatohepatitis (MASH), type 2 diabetes, and the broader systemic effects of dual‑receptor signalling.
At Chinese Grey Peptides, we supply high‑purity Survodutide research peptide to research institutions and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is lyophilised, HPLC‑verified to ≥99% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into metabolic regulation, obesity, and diabetes research begin with uncompromising quality.
What Is Survodutide and How Does It Work?
To fully appreciate the research potential of Survodutide research peptide, it is essential to understand its biochemical design and the precise mechanisms by which it exerts its pleiotropic metabolic effects.
The Balanced Dual‑Receptor Agonist
Survodutide (BI 456906) is a synthetic 29‑amino‑acid peptide engineered as a balanced dual agonist of the glucagon receptor (GCGR) and the glucagon‑like peptide‑1 receptor (GLP‑1R). The peptide incorporates a non‑coded amino acid (1‑aminocyclobutane‑1‑carboxylic acid) at position 2 to enhance proteolytic stability, and a C18 fatty diacid moiety conjugated via a glycine‑serine linker to extend half‑life through albumin binding. Its molecular formula is C₁₉₂H₂₈₉N₄₇O₆₁, with a molecular weight of approximately 4,231.62 g/mol and a CAS number of 2805997‑46‑8.
Mechanism of Action: Balanced GCGR and GLP‑1R Activation
The biological activity of Survodutide research peptide is mediated through its potent and balanced activation of two distinct G‑protein‑coupled receptors:
-
Glucagon Receptor (GCGR) Activation: Survodutide binds to GCGR with high affinity, promoting energy expenditure, fatty acid oxidation, and thermogenesis. This pathway is distinct from incretin‑based mechanisms and provides a complementary route for metabolic regulation.
-
GLP‑1 Receptor (GLP‑1R) Activation: Survodutide binds to GLP‑1R, stimulating glucose‑dependent insulin secretion, suppressing appetite, and delaying gastric emptying.
-
Synergistic Metabolic Effects: The balanced combination of GCGR and GLP‑1R activation produces synergistic effects on body weight and glycaemic control that are greater than those achieved with either pathway alone.
Research Note: Clinical Development
Survodutide has progressed into Phase 3 clinical trials for obesity and MASH, demonstrating substantial weight loss and improvements in liver fat content. In Phase 2 trials for MASH with fibrosis, Survodutide demonstrated substantial improvements in liver fat content and fibrosis resolution. In a Phase 2 study, Survodutide achieved up to 18.7% weight loss in people with obesity and type 2 diabetes.
Key Research Applications for Survodutide Research Peptide
Survodutide research peptide is a versatile tool with applications spanning several domains of biomedical research.
1. Obesity & Weight Regulation Research
Survodutide has demonstrated robust, dose‑dependent weight loss in clinical and preclinical models. Research applications include:
-
Energy Balance Studies: Investigating how balanced GCGR and GLP‑1R activation modulates appetite, satiety, and energy expenditure.
-
Weight Loss Mechanisms: Studying the molecular basis of weight reduction in diet‑induced obese (DIO) mouse models.
-
Dose‑Response Studies: Characterising the dose‑dependent effects of Survodutide on body weight, waist circumference, and metabolic parameters.
2. Metabolic Dysfunction‑Associated Steatohepatitis (MASH) Research
Survodutide has demonstrated potent efficacy in hepatic metabolism models. Research applications include:
-
Hepatic Fat Reduction: Investigating the effects of balanced GCGR/GLP‑1R activation on liver fat content.
-
Fibrosis Resolution: Studying the potential anti‑fibrotic effects of dual agonism on hepatic tissue.
-
Hepatic Lipid Metabolism: Exploring how GCGR activation promotes fatty acid oxidation and reduces hepatic fat accumulation.
3. Type 2 Diabetes Research
Survodutide has demonstrated significant glycaemic control in clinical trials. Research applications include:
-
Glycaemic Control Studies: Investigating the effects of Survodutide on HbA1c reduction and glucose homeostasis.
-
Insulin Sensitivity: Studying the role of GLP‑1R activation in enhancing glucose‑dependent insulin secretion.
-
Comparative Studies: Comparing Survodutide with other GLP‑1 receptor agonists and dual agonists.
4. Cardiovascular & Metabolic Research
Survodutide is being investigated for its effects on cardiovascular health. Research applications include:
-
Cardiovascular Risk Factors: Investigating improvements in blood pressure, lipid profiles, and inflammatory markers.
-
Cardiovascular‑Metabolic Research: Exploring the broader therapeutic potential of balanced dual agonism in addressing the interconnected pathways of cardiovascular and metabolic disease.
5. Appetite & Satiety Signalling Research
Survodutide’s dual mechanism provides a model for studying appetite regulation:
-
Central Appetite Pathways: Investigating how GCGR and GLP‑1R activation modulates hypothalamic and brainstem circuits involved in feeding behaviour.
-
Satiety Signalling: Studying the role of dual agonism in promoting satiety and reducing caloric intake.
Chemical & Physical Specifications
Accurate characterisation of Survodutide research peptide is essential for reproducible experimental design.
| Parameter | Specification |
|---|---|
| Common Names | Survodutide, BI 456906 |
| Amino Acid Count | 29 amino acids (synthetic peptide) |
| Molecular Formula | C₁₉₂H₂₈₉N₄₇O₆₁ |
| Molecular Weight | ~4,231.62 g/mol |
| CAS Number | 2805997‑46‑8 |
| Purity | ≥99% (HPLC verified) |
| Appearance | White to off‑white lyophilised powder |
| Solubility | Soluble in sterile water and sterile PBS (pH 5‑7) |
| Storage (Lyophilised) | –20°C, sealed, protected from light; stable for up to 2 years |
| Storage (Reconstituted) | 2‑8°C for short‑term use; single‑use aliquots at –20°C for long‑term storage |
Note: Survodutide is supplied as a lyophilised powder for research use only (RUO). It is not FDA‑approved for human use and is supplied strictly for in‑vitro and in‑vivo scientific research.
Reconstitution & Handling Protocol for Survodutide
Proper reconstitution of Survodutide research peptide is critical for maintaining its structural integrity and biological activity.
Step 1 – Preparation
-
Bring the sealed Survodutide vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH 5‑7) to room temperature. Condensation can degrade the lyophilised powder.
-
Clean your work surface with 70% ethanol and lay out sterile syringes, alcohol wipes and a clean work mat.
Step 2 – Vial Sanitisation
-
Wipe the rubber stopper of the Survodutide vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely before piercing.
Step 3 – Reconstitution
-
Draw your desired volume of diluent into a sterile syringe. A common starting concentration for research applications is 1‑2 mg per 1 mL of diluent, yielding a 1‑2 mg/mL stock solution.
-
Insert the needle and slowly inject the diluent against the inner glass wall. Do not spray directly onto the lyophilised powder.
-
Gently swirl the vial until the solution is clear and fully dissolved. Do not shake vigorously, as shaking can cause denaturation.
Step 4 – Aliquoting & Storage
-
Immediately after dissolution, aliquot the reconstituted Survodutide into single‑use sterile vials.
-
Store aliquots at –20°C. Avoid repeated freeze‑thaw cycles, as peptides are susceptible to degradation.
-
Once thawed, store at 2‑8°C and use within a short period.
Concentration Reference Table
| Vial Mass | Diluent Volume | Final Concentration |
|---|---|---|
| 1 mg | 1.0 mL | 1 mg/mL |
| 5 mg | 2.5 mL | 2 mg/mL |
| 10 mg | 5.0 mL | 2 mg/mL |
Adjust diluent volume based on your experimental requirements. For cell culture applications, typical working concentrations may range from 0.1‑10 µM.
Storage & Stability Guidelines
| Storage Condition | Shelf Life | Notes |
|---|---|---|
| Lyophilised at –20°C, unopened | 2 years | Use desiccant, protect from light |
| Lyophilised at 2‑8°C, unopened | 6‑12 months | –20°C storage is strongly preferred for long‑term stability |
| Reconstituted at 2‑8°C | Short‑term use | Use within days to weeks |
| Reconstituted aliquots at –20°C | Up to 3 months | Single freeze only; discard after thawing |
Why Choose Chinese Grey Peptides for Survodutide?
As an authentic licensed peptide supplier based in the USA, we supply Survodutide research peptide and a wide range of research‑grade compounds under rigorous quality assurance protocols, fully aligned with Google’s E‑E‑A‑T standards (Experience, Expertise, Authoritativeness, Trustworthiness).
-
Verified Purity: Independent HPLC analysis with purity guaranteed ≥99% for every batch.
-
GMP‑Compliant Manufacturing: All peptides are synthesised under strict quality control conditions.
-
Full Traceability: Batch‑specific Certificates of Analysis (COA) are available for every order.
-
Wholesale Supply: We serve research institutions, laboratories, and wholesale buyers across the UK, EU, and USA with flexible volume pricing and reliable logistics.
-
USA‑Based Regulatory Compliance: All products are supplied strictly as research‑grade reagents for laboratory use only (RUO).
Researchers across the United States—including those at leading institutions—trust us for fast domestic delivery, transparent documentation and professional technical support.
FAQ: Survodutide Research Peptide
What is Survodutide research peptide?
Survodutide (BI 456906) is a synthetic 29‑amino‑acid peptide that functions as a balanced dual agonist of the glucagon receptor (GCGR) and the glucagon‑like peptide‑1 receptor (GLP‑1R). It is used in research to study obesity, MASH, type 2 diabetes, and metabolic regulation.
What is the sequence and molecular weight of Survodutide?
Survodutide is a 29‑amino‑acid peptide with a molecular formula of C₁₉₂H₂₈₉N₄₇O₆₁ and a molecular weight of approximately 4,231.62 g/mol. It has a CAS number of 2805997‑46‑8.
What is the mechanism of action of Survodutide?
Survodutide acts as a balanced dual agonist of GCGR and GLP‑1R, promoting energy expenditure and fatty acid oxidation (via GCGR) while suppressing appetite and enhancing glucose‑dependent insulin secretion (via GLP‑1R).
What are the primary research applications for Survodutide?
Survodutide is used in obesity and weight regulation research, MASH and hepatic metabolism research, type 2 diabetes research, cardiovascular and metabolic research, and appetite and satiety signalling research.
What clinical trial data support Survodutide’s efficacy?
In Phase 2 trials, Survodutide achieved up to 18.7% weight loss in people with obesity and type 2 diabetes. In MASH trials, it demonstrated substantial improvements in liver fat content and fibrosis resolution. Survodutide has progressed into Phase 3 clinical trials.
What purity does your Survodutide research peptide meet?
Our Survodutide is tested to ≥99% purity by HPLC. A Certificate of Analysis (COA) is supplied with every order.
How should I reconstitute Survodutide research peptide?
Reconstitute with sterile bacteriostatic water or sterile PBS (pH 5‑7). Allow the vial to reach room temperature, then slowly inject the diluent against the inner glass wall and swirl gently. Do not shake.
How should I store reconstituted Survodutide?
Reconstituted Survodutide should be stored at 2‑8°C for short‑term use. For longer storage, aliquot immediately into single‑use vials and store at –20°C for up to 3 months. Avoid repeated freeze‑thaw cycles.
Is Survodutide research peptide legal to purchase in the USA?
Yes. Survodutide is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess, and use in the United States for legitimate in‑vitro or in‑vivo scientific research, provided it is not marketed with therapeutic claims.
Does Chinese Grey Peptides ship internationally?
Yes. We ship across the UK, Europe (France, Germany, Spain, Sweden, Italy), and the USA from our US warehouse. Wholesale pricing is available for bulk orders.
Ships to USA, Canada, UK & Europe
Chinese Grey Peptides supports shipping to the USA, Canada, the United Kingdom, France, Germany, Spain, Sweden, Italy, and Europe where permitted.
Shipping support may include:
- Order processing updates
- Packaging support
- Tracking information where available
- Wholesale shipment planning
- Destination-based shipping review
- Customer support during transit
Shipping times may vary by order size, carrier, destination, customs process, and local requirements.
Why Choose Chinese Grey Peptides?
Chinese Grey Peptides focuses on quality, support, and clear communication. We help buyers review product details before placing an order.
Customers choose us for:
- Professional peptide supplier support
- Small and wholesale order options
- Product documentation support
- HPLC testing information where available
- Mass Spectrum documentation where available
- International shipping support
- Responsive communication
- Clear order assistance before payment
We aim to make the buying process simple, transparent, and professional.
- Shop Page
- Bulk Orders Page
- Contact Page
- Shipping & Return Page
- Peptide Purity Page
- PubChem Survodutide
- FDA GSRS Survodutide
- IUPHAR/BPS Survodutide ligand page
- FDA peptide warning letter
From its design as a balanced dual agonist of GCGR and GLP‑1R to its well‑characterised role in promoting energy expenditure, suppressing appetite, and improving glycaemic control, Survodutide research peptide provides a precisely defined and mechanistically advanced platform for metabolic research. Its ability to simultaneously activate appetite‑suppressing and energy‑expending pathways—supported by Phase 2 clinical data demonstrating up to 18.7% weight loss and substantial improvements in liver fat content—makes it a valuable addition to any laboratory investigating obesity, MASH, type 2 diabetes, or the broader systemic effects of dual‑receptor signalling. By choosing high‑purity, lab‑verified Survodutide research peptide from Chinese Grey Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.
Ready to advance your research with Survodutide? Browse our product catalogue, request a wholesale quote, or contact our support team today to discuss your laboratory’s specific needs. Place your order now and receive GMP‑grade Survodutide delivered directly to your facility in the USA, UK, or Europe.




Reviews
There are no reviews yet.